English
中文繁體
中文简体

Dark
Light

Open Account

US OptionsDetailed Quotes

ERAS250516C7500

Watchlist

0.00
0.000.00%

15min DelayTrading May 8 09:30 ET

0.00High0.00Low

Erasca Stock Discussion

Sign in to post a comment

$Erasca (ERAS.US)$

Erasca to Present at the Bank of America Securities Health Care Conference

2

Swing Trading. 🔑

$Erasca (ERAS.US)$

2

$Erasca (ERAS.US)$

Erasca Price Target Maintained With a $6.00/Share by HC Wainwright & Co.

1

Erasca Presents New Preclinical Data Reinforcing Best-in-Class Potential of RAS-Targeting Franchise at the 2025 AACR Annual Meeting

$Erasca (ERAS.US)$
New Cancer Drug Data: Erasca's RAS Inhibitors Show Best-in-Class Potential at AACR 2025

Erasca Presents New Preclinical Data Reinforcing Best-in-Class Potential of RAS-Targeting Franchise at the 2025 AACR Annual Meeting

2

$Erasca (ERAS.US)$

BofA Securities Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $5

$Erasca (ERAS.US)$

BofA Securities Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $5

$Erasca (ERAS.US)$

Morgan Stanley Initiates Erasca(ERAS.US) With Buy Rating, Announces Target Price $4

$Erasca (ERAS.US)$

Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference

$Erasca (ERAS.US)$

Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference

$Erasca (ERAS.US)$

BofA Securities Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $5

1

No comment yet